Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C36H56O13.2H2O |
| Molecular Weight | 732.8526 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 17 / 17 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.CO[C@H]1C[C@H](O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)O[C@H](C)[C@H]1O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O
InChI
InChIKey=RPHSJGGDDBGGDS-MQYWENBJSA-N
InChI=1S/C36H56O13.2H2O/c1-18-31(49-32-30(41)29(40)28(39)25(16-37)48-32)24(44-4)14-27(46-18)47-20-5-9-33(2)22-6-10-34(3)21(19-13-26(38)45-17-19)8-12-36(34,43)23(22)7-11-35(33,42)15-20;;/h13,18,20-25,27-32,37,39-43H,5-12,14-17H2,1-4H3;2*1H2/t18-,20+,21-,22+,23-,24+,25-,27+,28-,29+,30-,31-,32+,33-,34-,35+,36+;;/m1../s1
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: ERK1/2-EGR1 pathway Sources: https://www.ncbi.nlm.nih.gov/pubmed/27160973 |
|||
Target ID: AKT/ERK signaling pathways Sources: https://www.ncbi.nlm.nih.gov/pubmed/21063098 |
|||
Target ID: beta-catenin/TCF signaling Sources: https://www.ncbi.nlm.nih.gov/pubmed/20596624 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
11018-76-1
Created by
admin on Mon Mar 31 22:35:53 GMT 2025 , Edited by admin on Mon Mar 31 22:35:53 GMT 2025
|
PRIMARY | |||
|
90478348
Created by
admin on Mon Mar 31 22:35:53 GMT 2025 , Edited by admin on Mon Mar 31 22:35:53 GMT 2025
|
PRIMARY | |||
|
m8559
Created by
admin on Mon Mar 31 22:35:53 GMT 2025 , Edited by admin on Mon Mar 31 22:35:53 GMT 2025
|
PRIMARY | Merck Index | ||
|
G8KEW6243X
Created by
admin on Mon Mar 31 22:35:53 GMT 2025 , Edited by admin on Mon Mar 31 22:35:53 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD